Literature DB >> 3805742

A simple, non-chromatographic procedure to purify immunoglobulins from serum and ascites fluid.

M M McKinney, A Parkinson.   

Abstract

A simple, two-step procedure to purify the immunoglobulin G (IgG) fraction from mammalian sera and ascites fluid is described. In the first step, albumin and other non-IgG proteins are precipitated with caprylic acid (octanoic acid). In the second, the IgG fraction is precipitated with ammonium sulfate. Factors influencing the precipitation of serum proteins by caprylic acid are described, as are procedural modifications to purify the IgG fraction from sera with a high lipid content. The procedure can be used to purify the IgG fraction of serum from rabbit, sheep, goat, horse, rat and mouse, as well as monoclonal antibodies from mouse ascites fluid. Greater than 80% of the IgG in rabbit serum could be isolated by this procedure, with a purity equal to rabbit IgG purified by anion-exchange chromatography. In addition to its simplicity and low cost, the procedure described offers several advantages over other methods to purify IgG.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3805742     DOI: 10.1016/0022-1759(87)90324-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  99 in total

1.  Nucleosides from Phlebotomus papatasi salivary gland ameliorate murine collagen-induced arthritis by impairing dendritic cell functions.

Authors:  Vanessa Carregaro; Anderson Sá-Nunes; Thiago M Cunha; Renata Grespan; Carlo J F Oliveira; Djalma S Lima-Junior; Diego L Costa; Waldiceu A Verri; Cristiane M Milanezi; Van My Pham; David D Brand; Jesus G Valenzuela; João S Silva; José M C Ribeiro; Fernando Q Cunha
Journal:  J Immunol       Date:  2011-09-19       Impact factor: 5.422

2.  Second Jenner international glycoimmunology meeting.

Authors: 
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

3.  Comparative structural analysis of transcriptionally competent and incompetent rotavirus-antibody complexes.

Authors:  J A Lawton; M K Estes; B V Prasad
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

4.  A second isoform of the ferredoxin:NADP oxidoreductase generated by an in-frame initiation of translation.

Authors:  Jean-Claude Thomas; Bettina Ughy; Bernard Lagoutte; Ghada Ajlani
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

5.  Inhibitory and anchoring domains in the ATPase inhibitor protein IF1 of bovine heart mitochondrial ATP synthase.

Authors:  Franco Zanotti; Gabriella Raho; Antonio Gaballo; Sergio Papa
Journal:  J Bioenerg Biomembr       Date:  2004-10       Impact factor: 2.945

6.  A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules.

Authors:  Nadine C Fernandez; Emmanuel Treiner; Russell E Vance; Amanda M Jamieson; Suzanne Lemieux; David H Raulet
Journal:  Blood       Date:  2005-02-22       Impact factor: 22.113

7.  Isolation of Mycobacterium paratuberculosis from milk by immunomagnetic separation.

Authors:  I R Grant; H J Ball; M T Rowe
Journal:  Appl Environ Microbiol       Date:  1998-09       Impact factor: 4.792

8.  Processing and secretion of a virally encoded antifungal toxin in transgenic tobacco plants: evidence for a Kex2p pathway in plants.

Authors:  H Kinal; C M Park; J O Berry; Y Koltin; J A Bruenn
Journal:  Plant Cell       Date:  1995-06       Impact factor: 11.277

9.  Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies.

Authors:  Vandana Hirani; Anton Yarovoy; Anita Kozeska; Ronald P Magnusson; Jerome M Lasker
Journal:  Arch Biochem Biophys       Date:  2008-07-16       Impact factor: 4.013

10.  Inhibition of Epstein-Barr-virus-transformed human chronic lymphocytic leukaemic B cells with monoclonal-antibody-adriamycin (doxorubicin) conjugates.

Authors:  Z Zhu; J Kralovec; T Ghose; M Mammen
Journal:  Cancer Immunol Immunother       Date:  1995-04       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.